Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Anemia 2 Uterine Cervical Neoplasms 1 Radiation Injuries 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Myelodysplastic Syndromes 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Erectile Dysfunction 1 Drug-Related Side Effects and Adverse Reactions 1 Bronchiolitis Obliterans Syndrome 1

Interventions

Cisplatin 150 Radiotherapy 121 Cetuximab 96 Docetaxel 60 Fluorouracil 56 Paclitaxel 45 Radiotherapy, Intensity-Modulated 41 Carboplatin 40 pembrolizumab 34 Surveys and Questionnaires 22 Erlotinib Hydrochloride 19 Nivolumab 18 Immunohistochemistry 16 Gefitinib 16 Drug Therapy 16 Gemcitabine 14 Pemetrexed 13 Gene Expression Profiling 13 durvalumab 12 Chemotherapy, Adjuvant 12 Radiation 11 Filgrastim 11 Bevacizumab 11 Surgical Procedures, Operative 10 Polymerase Chain Reaction 10 Amifostine 10 Celecoxib 9 Capecitabine 9 Standard of Care 8 Neoadjuvant Therapy 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Head and Neck Neoplasms × Erythropoietin × Clear all

NCT01467115 2017-05-09

DREXNECK

Drexel University

Phase 2 Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡